MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 456.08 Thousand CAD | -10.68% |
| 2022 | 510.6 Thousand CAD | -9.32% |
| 2021 | 563.1 Thousand CAD | 6.23% |
| 2020 | 530.06 Thousand CAD | -38.38% |
| 2019 | 860.24 Thousand CAD | -20.89% |
| 2018 | 1.08 Million CAD | -0.53% |
| 2017 | 1.09 Million CAD | 33.8% |
| 2016 | 817.05 Thousand CAD | -30.25% |
| 2015 | 1.17 Million CAD | 33.46% |
| 2014 | 877.73 Thousand CAD | 51.43% |
| 2013 | 579.64 Thousand CAD | -20.41% |
| 2012 | 728.28 Thousand CAD | -16.54% |
| 2011 | 872.58 Thousand CAD | 32.74% |
| 2010 | 657.35 Thousand CAD | 45.63% |
| 2009 | 451.37 Thousand CAD | -60.73% |
| 2008 | 1.14 Million CAD | 8.87% |
| 2007 | 1.05 Million CAD | -59.34% |
| 2006 | 2.59 Million CAD | -11.45% |
| 2005 | 2.93 Million CAD | 6.92% |
| 2004 | 2.74 Million CAD | 107.76% |
| 2003 | 1.31 Million CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 104.3 Thousand CAD | -2.29% |
| 2024 Q1 | 106.74 Thousand CAD | 60.93% |
| 2023 FY | 456.08 Thousand CAD | -10.68% |
| 2023 Q4 | 66.33 Thousand CAD | -40.38% |
| 2023 Q2 | 229.74 Thousand CAD | 367.14% |
| 2023 Q1 | 49.18 Thousand CAD | -76.89% |
| 2023 Q3 | 111.25 Thousand CAD | -51.57% |
| 2022 FY | 510.6 Thousand CAD | -9.32% |
| 2022 Q2 | 142.97 Thousand CAD | 121.22% |
| 2022 Q4 | 212.8 Thousand CAD | 135.97% |
| 2022 Q1 | 64.63 Thousand CAD | -69.62% |
| 2022 Q3 | 90.18 Thousand CAD | -36.92% |
| 2021 FY | 563.1 Thousand CAD | 6.23% |
| 2021 Q4 | 212.76 Thousand CAD | 126.0% |
| 2021 Q1 | 109.65 Thousand CAD | -42.94% |
| 2021 Q2 | 146.53 Thousand CAD | 33.63% |
| 2021 Q3 | 94.14 Thousand CAD | -35.75% |
| 2020 FY | 530.06 Thousand CAD | -38.38% |
| 2020 Q1 | 95.54 Thousand CAD | -47.32% |
| 2020 Q4 | 192.18 Thousand CAD | 11.16% |
| 2020 Q2 | 69.45 Thousand CAD | -27.31% |
| 2020 Q3 | 172.88 Thousand CAD | 148.93% |
| 2019 Q2 | 259.1 Thousand CAD | 40.21% |
| 2019 Q3 | 234.97 Thousand CAD | -9.31% |
| 2019 FY | 860.24 Thousand CAD | -20.89% |
| 2019 Q4 | 181.36 Thousand CAD | -22.82% |
| 2019 Q1 | 184.8 Thousand CAD | -32.85% |
| 2018 Q3 | 180.4 Thousand CAD | -55.53% |
| 2018 Q4 | 275.19 Thousand CAD | 52.54% |
| 2018 FY | 1.08 Million CAD | -0.53% |
| 2018 Q1 | 226.12 Thousand CAD | -37.41% |
| 2018 Q2 | 405.7 Thousand CAD | 79.42% |
| 2017 Q4 | 361.26 Thousand CAD | 41.52% |
| 2017 Q1 | 239.81 Thousand CAD | 134.22% |
| 2017 Q2 | 236.89 Thousand CAD | -1.22% |
| 2017 FY | 1.09 Million CAD | 33.8% |
| 2017 Q3 | 255.26 Thousand CAD | 7.76% |
| 2016 Q2 | 209.49 Thousand CAD | 11.02% |
| 2016 Q1 | 188.7 Thousand CAD | -44.43% |
| 2016 Q3 | 317.42 Thousand CAD | 51.52% |
| 2016 FY | 817.05 Thousand CAD | -30.25% |
| 2016 Q4 | 102.38 Thousand CAD | -67.74% |
| 2015 FY | 1.17 Million CAD | 33.46% |
| 2015 Q1 | 298.61 Thousand CAD | 45.89% |
| 2015 Q4 | 339.56 Thousand CAD | 104.59% |
| 2015 Q3 | 165.97 Thousand CAD | -54.81% |
| 2015 Q2 | 367.25 Thousand CAD | 22.98% |
| 2014 FY | 877.73 Thousand CAD | 51.43% |
| 2014 Q3 | 295.24 Thousand CAD | 34.19% |
| 2014 Q2 | 220.01 Thousand CAD | 39.45% |
| 2014 Q1 | 157.77 Thousand CAD | -1.73% |
| 2014 Q4 | 204.69 Thousand CAD | -30.67% |
| 2013 Q1 | 119.42 Thousand CAD | -38.22% |
| 2013 Q4 | 160.55 Thousand CAD | 46.9% |
| 2013 FY | 579.64 Thousand CAD | -20.41% |
| 2013 Q2 | 190.36 Thousand CAD | 59.4% |
| 2013 Q3 | 109.29 Thousand CAD | -42.59% |
| 2012 FY | 728.28 Thousand CAD | -16.54% |
| 2012 Q4 | 193.32 Thousand CAD | 11.27% |
| 2012 Q3 | 173.74 Thousand CAD | 9.94% |
| 2012 Q2 | 158.04 Thousand CAD | -22.21% |
| 2012 Q1 | 203.17 Thousand CAD | -47.81% |
| 2011 Q4 | 389.3 Thousand CAD | 114.65% |
| 2011 Q2 | 174.95 Thousand CAD | 37.8% |
| 2011 Q1 | 126.96 Thousand CAD | -51.89% |
| 2011 FY | 872.58 Thousand CAD | 32.74% |
| 2011 Q3 | 181.37 Thousand CAD | 3.67% |
| 2010 Q1 | 166.03 Thousand CAD | 285.69% |
| 2010 FY | 657.35 Thousand CAD | 45.63% |
| 2010 Q2 | 79.42 Thousand CAD | -52.16% |
| 2010 Q3 | 155.17 Thousand CAD | 95.37% |
| 2010 Q4 | 263.89 Thousand CAD | 70.06% |
| 2009 Q2 | 106.62 Thousand CAD | -69.67% |
| 2009 Q1 | 351.57 Thousand CAD | 35.69% |
| 2009 FY | 451.37 Thousand CAD | -60.73% |
| 2009 Q3 | 82.59 Thousand CAD | -22.54% |
| 2009 Q4 | -89.41 Thousand CAD | -208.26% |
| 2008 Q4 | 259.09 Thousand CAD | -22.79% |
| 2008 Q3 | 335.56 Thousand CAD | 29.45% |
| 2008 Q1 | 295.58 Thousand CAD | 230.48% |
| 2008 Q2 | 259.23 Thousand CAD | -12.3% |
| 2008 FY | 1.14 Million CAD | 8.87% |
| 2007 Q2 | 344.88 Thousand CAD | 10.29% |
| 2007 Q1 | 312.71 Thousand CAD | -45.04% |
| 2007 Q3 | 308.75 Thousand CAD | -10.48% |
| 2007 Q4 | 89.44 Thousand CAD | -71.03% |
| 2007 FY | 1.05 Million CAD | -59.34% |
| 2006 Q2 | 720.59 Thousand CAD | -10.35% |
| 2006 Q1 | 803.79 Thousand CAD | -8.62% |
| 2006 FY | 2.59 Million CAD | -11.45% |
| 2006 Q3 | 508.11 Thousand CAD | -29.49% |
| 2006 Q4 | 569.01 Thousand CAD | 11.98% |
| 2005 Q4 | 879.58 Thousand CAD | 72.07% |
| 2005 FY | 2.93 Million CAD | 6.92% |
| 2005 Q1 | 699.83 Thousand CAD | 3.35% |
| 2005 Q2 | 841.52 Thousand CAD | 20.25% |
| 2005 Q3 | 511.17 Thousand CAD | -39.26% |
| 2004 FY | 2.74 Million CAD | 107.76% |
| 2004 Q1 | 465.45 Thousand CAD | 0.0% |
| 2004 Q3 | 709.41 Thousand CAD | -20.37% |
| 2004 Q4 | 677.16 Thousand CAD | -4.55% |
| 2004 Q2 | 890.93 Thousand CAD | 91.41% |
| 2003 FY | 1.31 Million CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.942% |
| QHSLab, Inc. | 1.4 Million USD | 67.63% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.942% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 11.98 Million USD | 96.193% |
| Aurora Spine Corporation | 14.52 Million USD | 96.859% |
| BrainsWay Ltd. | 31.78 Million USD | 98.565% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 99.098% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 99.334% |
| BioElectronics Corporation | 714.7 Thousand USD | 36.185% |
| Vivos Inc. | 19.5 Thousand USD | -2238.913% |
| Kelyniam Global, Inc. | 2.67 Million USD | 82.933% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -426.6% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -123.882% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 99.133% |
| Avitar, Inc. | 3.1 Million USD | 85.317% |
| Nanomix Corporation | 15.45 Thousand USD | -2852.026% |
| Theraclion SA | 1.82 Million USD | 74.971% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 31.058% |
| NewCardio, Inc. | 257.39 Thousand USD | -77.191% |
| Positron Corporation | 734.66 Thousand USD | 37.919% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 66.186% |
| Lombard Medical, Inc. | 12.16 Million USD | 96.252% |
| ALR Technologies Inc. | 7468.00 USD | -6007.231% |
| Stratec SE | 289.14 Million USD | 99.842% |
| Vycor Medical, Inc. | 1.46 Million USD | 68.774% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.952% |
| VMS Rehab Systems, Inc. | 71.70 USD | -636005.997% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -365.396% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 36.714% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -439.851% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 97.764% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -13.024% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | 48.808% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 83.97% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 83.812% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 86.191% |
| SS Innovations International, Inc. | 5.87 Million USD | 92.243% |
| Urologix, Inc. | 14.23 Million USD | 96.796% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -1035.253% |
| Smith & Nephew plc | 5.68 Billion USD | 99.992% |
| NIOX Group Plc | 46.84 Million USD | 99.026% |
| Fuse Medical, Inc. | 16.11 Million USD | 97.17% |
| Broncus Holding Corporation | 10.25 Million USD | 95.553% |
| Brain Scientific Inc. | 214.56 Thousand USD | -112.565% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 76.939% |
| Health Logic Interactive Inc. | - USD | -Infinity% |